The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, including healthcare providers, about Phesgo, a suspected counterfeit cancer treatment drug.
The alert on the circulation of the drug was published on
the agency’s website.
NAFDAC said a doctor at the Lagos University Teaching
Hospital (LUTH) had raised concerns about the drug after a patient brought it
in.
The agency said the product had not been administered, but
it matched the characteristics of a previously reported counterfeit batch,
C3809C51.
“The National Agency for Food and Drugs Administration and
Control (NAFDAC) wishes to inform healthcare providers and the public of a
report of a suspected counterfeit Phesgo® 600mg/600mg/10ml, labelled with batch
C5290S20,” the statement reads.
“The Marketing Authorisation Holder (MAH) Roche received a complaint
from a doctor at Lagos University Teaching Hospital (LUTH-NSIA) reporting a
suspected counterfeit Phesgo® 600mg/600mg, labelled with batch C5290S20.
“The product was reported to have been brought in by a
patient for administration. It had not been administered at the time of the
report, as it matched the previously reported counterfeit batch: C3809C51.
“Although no sample was returned to Roche for investigation,
only pictures displaying parts of a Phesgo® 600mg/600mg in a 10ml folding box
and a labelled vial.
“Images of the suspected product were examined by Roche and
compared to the genuine samples retained for reference.
“Although no physical sample was returned to Roche for
investigation, images of parts of the product specifically, a Phesgo
600mg/600mg vial and a 10ml folding box were examined.
“The suspected product’s images were compared to genuine
samples retained by Roche.
“Roche’s investigation identified several significant
differences between the complaint sample and genuine materials, confirming the
counterfeit status of the batch.
“These included: no batch number in the MAH database,
discrepancies in language, missing basilisk, incorrect bollino date, and
tampered evidence labels that did not match genuine Roche materials.”
NAFDAC added that “since no physical sample was available
for chemical analysis”, the investigation was “limited to visual comparisons”.
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com